Biora Therapeutics, Inc. Proceeds from Convertible Debt
Biora Therapeutics, Inc. reported Proceeds from Convertible Debt of $10.81 million for the 9-month period ending 2024-09-30, per its 10-Q filed 2024-11-14.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromConvertibleDebt · last filed 2024-11-14
- Biora Therapeutics, Inc. proceeds from convertible debt for the quarter ending 2024-09-30 was $8.00M.
- Biora Therapeutics, Inc. proceeds from convertible debt for the quarter ending 2024-06-30 was $0.00.
- Biora Therapeutics, Inc. proceeds from convertible debt for the quarter ending 2024-03-31 was $2.81M.
- Biora Therapeutics, Inc. proceeds from convertible debt for the quarter ending 2023-12-31 was $10.00M.
- Biora Therapeutics, Inc. proceeds from convertible debt for fiscal 2023 was $10.00M.
- Biora Therapeutics, Inc. proceeds from convertible debt for fiscal 2022 was $0.00.
- Biora Therapeutics, Inc. proceeds from convertible debt for fiscal 2021 was $0.00, a 100.00% decline from fiscal 2020.
- Biora Therapeutics, Inc. proceeds from convertible debt for fiscal 2020 was $99.71M.
| Period end | Proceeds from Convertible Debt 3 month | Proceeds from Convertible Debt 6 month | Proceeds from Convertible Debt 9 month | Proceeds from Convertible Debt 12 month |
|---|---|---|---|---|
| 2024-09-30 | $8.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | $8.00M derived: sum of 2 quarters · filed 2024-11-14 | $10.81M 10-Q · filed 2024-11-14 | $20.81M derived: sum of 4 quarters · filed 2024-11-14 |
| 2024-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-12 | $2.81M 10-Q · filed 2024-08-12 | $12.81M derived: sum of 3 quarters · filed 2024-08-12 | $12.81M derived: sum of 4 quarters · filed 2024-11-14 |
| 2024-03-31 | $2.81M 10-Q · filed 2024-05-15 | $12.81M derived: sum of 2 quarters · filed 2024-05-15 | $12.81M derived: sum of 3 quarters · filed 2024-11-14 | $12.81M derived: sum of 4 quarters · filed 2024-11-14 |
| 2023-12-31 | $10.00M derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | $10.00M derived: sum of 2 quarters · filed 2024-11-14 | $10.00M derived: sum of 3 quarters · filed 2024-11-14 | $10.00M 10-K · filed 2024-04-01 |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | $0.00 derived: sum of 2 quarters · filed 2024-11-14 | $0.00 10-Q · filed 2024-11-14 | |
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-12 | $0.00 10-Q · filed 2024-08-12 | ||
| 2023-03-31 | $0.00 10-Q · filed 2024-05-15 | |||
| 2022-12-31 | $0.00 10-K · filed 2024-04-01 | |||
| 2021-12-31 | $0.00 10-K · filed 2022-03-28 | |||
| 2020-12-31 | $84.81M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-28 | $84.81M derived: sum of 2 quarters · filed 2022-03-28 | $99.71M 10-K · filed 2022-03-28 | |
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | $14.89M 10-Q · filed 2021-11-10 | ||
| 2020-06-30 | $14.89M 10-Q · filed 2021-08-12 |